Literature DB >> 9837987

Homologous recombination is required for the viability of rad27 mutants.

L S Symington1.   

Abstract

The RAD27/RTH1 gene of Saccharomyces cerevisiae encodes a structural and functional homolog of the 5'-3' exonuclease function of Escherichia coli DNA polymerase I. Four alleles of RAD27 were recovered in a screen for hyper-recombination, a phenotype also displayed by polA mutants of E.coli. All four rad27 mutants showed similar high levels of mitotic recombination, but varied in their growth rate at various temperatures, and sensitivity to the DNA damaging agent methyl methane sulfonate. Dependence of viability of rad27 strains on recombination was determined by crossing a strain containing a null allele of RAD27 to strains containing a mutation in either the RAD1, RAD50, RAD51, RAD52, RAD54, RAD55, RAD57, MRE11, XRS2 or RAD59 gene. In no case were viable spore products recovered that contained both mutations. Elimination of the non-homologous end-joining pathway did not affect the viability of a rad27 strain. This suggests that lesions generated in the absence of RAD27 must be processed by homologous recombination.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9837987      PMCID: PMC148039          DOI: 10.1093/nar/26.24.5589

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  68 in total

1.  Sister chromatid gene conversion is a prominent double-strand break repair pathway in mammalian cells.

Authors:  R D Johnson; M Jasin
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

Review 2.  Rescue of arrested replication forks by homologous recombination.

Authors:  B Michel; M J Flores; E Viguera; G Grompone; M Seigneur; V Bidnenko
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

3.  Two different Swi5-containing protein complexes are involved in mating-type switching and recombination repair in fission yeast.

Authors:  Yufuko Akamatsu; Dorota Dziadkowiec; Mitsunori Ikeguchi; Hideo Shinagawa; Hiroshi Iwasaki
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-08       Impact factor: 11.205

4.  Ku prevents Exo1 and Sgs1-dependent resection of DNA ends in the absence of a functional MRX complex or Sae2.

Authors:  Eleni P Mimitou; Lorraine S Symington
Journal:  EMBO J       Date:  2010-08-20       Impact factor: 11.598

5.  Genetic instability induced by overexpression of DNA ligase I in budding yeast.

Authors:  Jaichandar Subramanian; Sangeetha Vijayakumar; Alan E Tomkinson; Norman Arnheim
Journal:  Genetics       Date:  2005-06-18       Impact factor: 4.562

6.  Identification of rad27 mutations that confer differential defects in mutation avoidance, repeat tract instability, and flap cleavage.

Authors:  Y Xie; Y Liu; J L Argueso; L A Henricksen; H I Kao; R A Bambara; E Alani
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

7.  Saccharomyces cerevisiae flap endonuclease 1 uses flap equilibration to maintain triplet repeat stability.

Authors:  Yuan Liu; Haihua Zhang; Janaki Veeraraghavan; Robert A Bambara; Catherine H Freudenreich
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

8.  Cancer predisposition and hematopoietic failure in Rad50(S/S) mice.

Authors:  Carla F Bender; Michael L Sikes; Ruth Sullivan; Leslie Erskine Huye; Michelle M Le Beau; David B Roth; Olga K Mirzoeva; Eugene M Oltz; John H J Petrini
Journal:  Genes Dev       Date:  2002-09-01       Impact factor: 11.361

9.  Specific synthetic lethal killing of RAD54B-deficient human colorectal cancer cells by FEN1 silencing.

Authors:  Kirk J McManus; Irene J Barrett; Yasaman Nouhi; Philip Hieter
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-13       Impact factor: 11.205

10.  The role of MRN in the S-phase DNA damage checkpoint is independent of its Ctp1-dependent roles in double-strand break repair and checkpoint signaling.

Authors:  Mary E Porter-Goff; Nicholas Rhind
Journal:  Mol Biol Cell       Date:  2009-02-11       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.